Introduced
by
To revise details calculations used to determine an insured person's overall contribution to any out-of-pocket maximum or any prescription drug cost-sharing requirement. This relates to “false claims act” that bans kickbacks and bribes on prescription drugs.
Referred to the Committee on Health Policy
Reported without amendment
Refer to the Committee on Ways and Means with the recommendation that the substitute (H-1) be adopted.
Referred to the Committee on Ways and Means
